Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about SAGE
Recent news which mentions SAGE
< Previous
1
2
3
4
5
6
7
8
9
Next >
What 7 Analyst Ratings Have To Say About Sage Therapeutics
October 20, 2021
Tickers
SAGE
Tags
BZI/AAR
SAGE
Market News
From
Benzinga
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
October 20, 2021
Tickers
ABT
BIIB
BKR
CSX
Tags
Federal Reserve
ISRG
NVAX
From
Benzinga
10 Biggest Price Target Changes For Wednesday
October 20, 2021
Tickers
AVIR
CE
CLW
CVX
Tags
Price Target
Benzinga
MU
From
Benzinga
Analyst Ratings For Sage Therapeutics
October 12, 2021
Tickers
SAGE
Tags
SAGE
BZI/AAR
Analyst Ratings
From
Benzinga
Rising Oil Prices and Yields Makes Market Navigation More Complex
October 05, 2021
Tickers
AAL
AAPL
AMZN
BABA
Tags
AAPL
JNJ
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Tickers
AMGN
ANNX
AOSL
ARGX
Tags
EQR
Analyst Ratings
PCT
From
Benzinga
Why Sage Therapeutics Shares Are Trading Higher Today
September 15, 2021
Tickers
SAGE
Tags
News
Trading Ideas
SAGE
From
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Tickers
ACAD
ADMA
ADTX
AFIB
Tags
ATNX
Market News
FBRX
From
Benzinga
7 Best Biotech Stocks to Buy in 2021 with Huge Upside
August 25, 2021
Tickers
AGIO
EXEL
JNJ
MRNA
Tags
Market News
Stocks to Buy
JNJ
From
InvestorPlace
Alta Vista Technology Earns Inc. 5000 Honors for 4th Straight Year
August 24, 2021
Tickers
SAGE
VAR
Tags
Software
Dynamics
Michigan
From
PRLog
5 Value Stocks In The Healthcare Sector
August 23, 2021
Tickers
BXRX
CI
NMTR
RLAY
Tags
News
Market News
SAGE
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
Tickers
NG
NGD
NKTR
NLTX
Tags
BZI/52Weeks
SYRS
TRIL
From
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Tickers
ABVC
ACAD
ACET
ADMA
Tags
ACAD
REGN
KNTE
From
Benzinga
Overview Of Value Stocks In The Healthcare Sector
August 16, 2021
Tickers
BXRX
COO
LXRX
SAGE
Tags
BXRX
COO
Benzinga
From
Benzinga
A Look Into Healthcare Sector Value Stocks
August 09, 2021
Tickers
AIKI
CODX
COO
ENDP
Tags
CODX
News
AIKI
From
Benzinga
Where Sage Therapeutics Stands With Analysts
August 04, 2021
Tickers
SAGE
Tags
SAGE
BZI/AAR
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Tickers
ABSI
ACET
AERI
AKRO
Tags
MRVI
TERN
ALKS
From
Benzinga
10 Biggest Price Target Changes For Wednesday
August 04, 2021
Tickers
AYX
AZN
BHG
CLX
Tags
Analyst Ratings
Market News
LULU
From
Benzinga
Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript
August 03, 2021
Tickers
SAGE
Tags
SAGE
Market News
From
Motley Fool
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
August 03, 2021
Tickers
SAGE
Tags
Phase 3 Trial
News
General
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 03, 2021
Tickers
ACET
AEI
ARNA
ATER
Tags
REAX
BZI/52Weeks
CNTA
From
Benzinga
Sage Therapeutics: Q2 Earnings Insights
August 03, 2021
Tickers
SAGE
Tags
SAGE
News
Earnings
From
Benzinga
Earnings Scheduled For August 3, 2021
August 03, 2021
Tickers
MTCH
MTRN
MYGN
NBIX
Tags
NCR
PUMP
QUAD
From
Benzinga
Analyst Ratings For Sage Therapeutics
July 29, 2021
Tickers
SAGE
Tags
BZI/AAR
SAGE
Benzinga
From
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Tickers
ABCL
ABOS
ACET
ACHL
Tags
MRSN
CTMX
NCNA
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
Tickers
MDGL
ME
MF
MIRM
Tags
ME
MKD
ORIC
From
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Tickers
ABCL
ABSI
ACET
ACHL
Tags
VOR
VECT
AZN
From
Benzinga
Could These 3 Potential Blockbusters Transform Biogen?
July 25, 2021
Tickers
BIIB
SAGE
Tags
Market News
SAGE
BIIB
From
Motley Fool
Is It Too Late to Buy Biogen Stock?
July 19, 2021
Tickers
BIIB
SAGE
Tags
BIIB
SAGE
Market News
From
Motley Fool
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
July 11, 2021
Tickers
BIIB
NVS
PFE
QURE
Tags
RHHBY
QURE
NVS
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.